We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Inadequate Care of Adults Born With Heart Disease

By HospiMedica staff writers
Posted on 15 May 2006
A new report shows that the provision of care in Europe for adults born with heart disease is inadequate, and there are too few specialist centers to support their ever-increasing numbers.

The report is the latest finding from the Euro Heart Survey on adult congenital heart disease (ACHD). More...
This part of the survey--the first in the world of its kind--examined how care is being organized in Europe, by analyzing data from 71 centers that agreed to fill in questionnaires. The research was published on-line during April 2006 in European Heart Journal, the journal of the European Society of Cardiology.

"Society has invested a lot towards increasing the life expectancy of these children, but seems less interested when they are grown up,” said lead author Dr. Philip Moons, an assistant professor at the Catholic University of Leuven (Belgium).

"Because we did not receive information for all centers in every country, we cannot draw conclusions about whether any individual country is better or worse than any other or whether a particular country has a sufficient number of centers,” continued Dr. Moons.

"Nor can we know to what extent this affects the outcome of treatment for patients. However, we can definitely say that the provision of care overall is suboptimal and there is much room for improvement. Certainly, our findings suggest that the number of adequately equipped centers is too limited to support the more than 1.2 million adults with congenital heart disease in Europe.

The report stressed that ACHD required an interdisciplinary teamwork approach, but care workers were being let down by the system. Dr. Moons concluded by stating it was imperative for all governments to invest in educating ACHD professionals and provide sufficient funds for the development of a well-structured program with specialized centers in every country.



Related Links:
Catholic University of Leuven

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.